Braze price target lowered to $30 from $40 at Oppenheimer

Oppenheimer lowered the firm’s price target on Braze (BRZE) to $30 from $40 and keeps an Outperform rating on the shares after the company’s business generated a strong finish to FY26. Q4 results show impressive bookings growth and continuing organic revenue acceleration driven by broad-based strength. Additionally, the top-line outperformance in Q4 flowed through to a record operating margin, Oppenheimer adds. Negatively, the firm notes that the initial FY27 guidance implies business deceleration.